TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915).

Jeffrey S Weber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.